April Wang
Senior Regulatory Affairs Manager
Ms. Wang is a senior regulatory affairs consultant specializing in the Chinese market with a Double Master’s Degree from Fudan University and Luiss Guido Carli University.
She has in-depth understanding on Chinese Pharmaceutical regulations and accumulated extensive hands-on experience with API DMF registration & regulatory consulting projects during daily work.
Ms. Wang has strong communication network with Chinese authorities including NMPA and CDE.
A successful track record with supporting international pharma with market entry into China including big and small pharma.
